☆ 4.2 Letter

Looking beyond ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae: in vitro activity of the novel meropenem-vaborbactam in combination with the old fosfomycin

JOURNAL OF CHEMOTHERAPY (2021)

Get Full Text
Add to Collection

Journal

JOURNAL OF CHEMOTHERAPY
Volume 33, Issue 8, Pages 598-600

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/1120009X.2021.1909939

Keywords

meropenem-vaborbactam; fosfomycin; synergism; ceftazidime-avibactam resistance; KPC; Enterobacterales

Categories

Oncology Infectious Diseases Pathology Pharmacology & Pharmacy

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.